In this featured collection, we put a spotlight on medication assisted treatment (MAT) for opioid use disorder (OUD). Research has proven that MAT is an evidence-based strategy for treating individuals with OUD; individuals who use MAT as part of their treatment and recovery plan are more likely to be retained in treatment and to have fewer adverse events such as opioid overdose and opioid overdose mortality.
This collection compiles research and implementation materials from the Improving Addiction Care Team (IMPACT) program from Oregon Health & Science University (OHSU). IMPACT is an interprofessional, hospital-based addictions team that provides addiction medicine consults to patients being treated at OHSU who have a substance use disorder (SUD).
Research has shown that integrated care models that provide medical care, substance use disorder (SUD) treatment and social and peer support services for pregnant women with substance use disorders improve outcomes for both mothers and babies. In this collection, we feature resources from programs in Oregon, Vermont, and Ohio. First, several resources from Project Nurture in Oregon, a Center of Excellence program that provides prenatal care, inpatient maternity care, and postpartum care for women with SUD as well as pediatric care for their infants: A 2-page overview of the Project Nurture model A 1 page guide that describes the partners implementing the Project Nurture model in different care settings A 3-minute video explaining the Project Nurture model A 10-minute video that highlights the important role peer support mentors play in the Project Nurture model Slides from a presentation explaining the Project Nurture model and presenting initial evaluation results A summary of a research study that evaluates outcomes for mothers and babies served by Project Nurture compared to mothers with SUD receiving treatment as usual This collection also includes the following resources from other state initiatives: A case study of the Children and Recovering Mothers (CHARM) Collaborative in Burlington, Vermont from…
Substance use disorder in families often leads to involvement in child welfare systems. Research shows that removal of a child from a family is traumatic for both the child and parents and can impede the parent’s journey to recovery. Many programs now employ family peer mentors or recovery specialists to work with the families on their treatment plan, connect parents and children to services and resources, and provide support as they go through a difficult process.
A 2 page overview of the maternal opiate medical support project that piloted a program to treat pregnant women with opioid use disorder (OUD) and their babies at MetroHealth Medical Center in Cleveland, Ohio. This brief overview provides limited information but the review indicates that coordinated, respectful care can improve outcomes for mothers with OUD and their infants.
This research study summary looks at Project Nurture, an integrated prenatal and postpartum care program for pregnant mothers with substance use disorder and their infants.
In 2017 the Camden Coalition of Healthcare Providers began a pilot in partnership with local addiction treatment providers and UnitedHealthCare to see if removing prior authorization requirements for buprenorphine would reduce barriers to treatment and improve patient and system outcomes.
This program evaluation looks at California’s implementation of a hub-and-spoke treatment system for opioid use disorder (OUD) during the program’s first year (August 2017 to July 2018).
This 2018 evaluation of a pilot program to develop integrated medication assisted treatment (MAT) programs at community health centers (CHCs) describes the lessons learned by 10 CHCs as they implemented new MAT programs at their clinics in California.
The comprehensive Mother & Baby Substance Exposure Toolkit was created by the California Perinatal Quality Care Collaborative, the California Maternal Quality Care Collaborative, and HMA Institute on Addiction. This toolkit provides information on treating mothers and newborns from the prenatal period through hospital discharge with a focus on opioid-related conditions.